1. Home > Latest Topics >

Levofloxacin - Preeminent Respiratory Fluoroquinolone

20 June, 2018

Levofloxacin - Preeminent Respiratory Fluoroquinolone


LATEST TOPICS

Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024
Managing severe infections: Practical approaches for antibiotic use, including combination therapy
05 March, 2024
Updating Traditional Approaches: Expert Insights on Addressing Urinary Tract Infections
26 February, 2024
Antibiotic resistance may be driven by diverse factors, including extreme climatic events
14 February, 2024

RELATED ARTICLES

Lower Respiratory Tract Infection (Pneumonia) – Chapter 4
18 July, 2023
Community-acquired pneumonia: Updates in local treatment strategy and clinical experience with levofloxacin
07 October, 2021
Community-acquired pneumonia: Insights into macrolide resistance and a review of levofloxacin use
05 July, 2021
Management of macrolide resistance in respiratory tract infections: An overview
09 June, 2021
Sitafloxacin for bacterial infections: A Thailand perspective
02 June, 2021